Silvia Vivarelli is a Senior Postdoctoral Fellow at the University of Catania, Italy. She received her MSc, with full marks and honors, in Pharmaceutical Biotechnology (University of Bologna, 2005). Following her DPhil in Translational and Molecular Medicine (University of Milano-Bicocca, 2010), during which she contributed to the characterization of mRNA splicing modulation during oxidative stress response, she moved to Cambridge, UK. From 2010 to 2015, she served as a Postdoc at the Gurdon Institute (Cambridge, UK) where she was mainly involved in the characterization of a potential drug target regulating colorectal cancer genesis and therapeutic response. Moreover, until 2017, she worked at the Horizon Discovery biotech company (Cambridge, UK), where she provided oncology translational research services to the biotech and pharma community, to support drug discovery programs throughout the pre‐clinical processes. In 2018, she moved back to the University of Catania, Italy. Within the Translational Oncology Laboratory (Head: Professor Massimo Libra), she is currently studying the molecular mechanisms possibly triggering tumorigenesis and tumor progression, with the main goal of identifying novel targets for cancer diagnosis, prognosis and treatment. Her main project is focused in uncovering the role of the transcription factor Yin Yang 1 in cancer genesis and progression. Additionally, she is interested in the characterization of the role of gut microbiota role in cancer initiation and therapy.